The final BCR-ABL1 mechanisms of transformation, as extensively studied in CML, are probably an altered cellular adhesion to stroma-cells and the matrix of bone marrow, triggering constitutively active mitogenic pathways together with inhibited apoptosis (28). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.